据北京媒体报道,国家食品药品监管总局近日发布通报称,国家药品不良反应病例报告数据库收到的病例报告显示,口服何首乌及其成方制剂可能有引起肝损伤的风险。据了解,何首乌为常用中药材,分生何首乌和制何首乌,在医疗和保健中使用广泛。口服何首乌及其成方制剂引起的肝损伤多呈可逆性,停药或对症治疗后,预 According to Beijing media reports, the State Food and Drug Administration recently issued a circular that the national case reports of adverse drug reactions case reports received show that oral Polygonum multiflorum and its preparations may have the risk of causing liver damage. It is understood that Polygonum multiflorum is commonly used Chinese herbal medicines, superficial Polygonum multiflorum and Polygonum multiflorum, widely used in health care and health care. Polygonum multiflorum and its prescriptions caused liver damage were mostly reversible, withdrawal or symptomatic treatment, the pre-